Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Chronic Pancreatitis II: Collaborative Care01:29

Chronic Pancreatitis II: Collaborative Care

532
The management of chronic pancreatitis is multifaceted, involving a comprehensive approach that includes thorough assessment, diagnostic testing, and a variety of management strategies.
Assessment:
532

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Linkage disequilibrium score regression identifies genetic correlations between hepatocellular carcinoma and clinically relevant traits.

International journal of cancer·2025
Same author

The impact of liver transplantation on endpoint selection in alcohol-associated hepatitis trials.

Hepatology communications·2025
Same author

Differentiating Ischemic Hepatitis from Acetaminophen Overdose in Acute Liver Failure: Role of Acetaminophen Adducts-Ischemic Hepatitis vs Acetaminophen Overdose.

Digestive diseases and sciences·2024
Same author

Designing clinical trials to address alcohol use and alcohol-associated liver disease: an expert panel Consensus Statement.

Nature reviews. Gastroenterology & hepatology·2024
Same author

Genome-wide association study identifies high-impact susceptibility loci for HCC in North America.

Hepatology (Baltimore, Md.)·2024
Same author

Indeterminate etiology of acute liver failure in North America: Less common, still grave prognosis.

Clinical transplantation·2023

Related Experiment Video

Updated: Apr 16, 2026

Intraoperative Strategy under Complex Vascular Adhesion for Laparoscopic Radical Resection of Bismuth-Corlette Type IIIb Perihilar Cholangiocarcinoma
05:22

Intraoperative Strategy under Complex Vascular Adhesion for Laparoscopic Radical Resection of Bismuth-Corlette Type IIIb Perihilar Cholangiocarcinoma

Published on: February 13, 2026

197

Screening for malignancy in primary sclerosing cholangitis (PSC).

Saira A Khaderi1, Norman L Sussman

  • 1Baylor College of Medicine, 6620 Main Street #1425, Houston, TX, 77030, USA.

Current Gastroenterology Reports
|March 20, 2015
PubMed
Summary
This summary is machine-generated.

Primary sclerosing cholangitis (PSC) patients face a high lifetime cancer risk, particularly cholangiocarcinoma. Regular screening with MRI/MRCP and CA 19-9 is recommended, alongside colonoscopies for those with inflammatory bowel disease.

More Related Videos

Complete Laparoscopic Radical Resection of Perihilar Cholangiocarcinoma Type IIIb
04:50

Complete Laparoscopic Radical Resection of Perihilar Cholangiocarcinoma Type IIIb

Published on: January 17, 2025

953
Endoscopic Ultrasound-Guided Biliary Drainage: Endoscopic Ultrasound-Guided Hepaticogastrostomy in Malignant Biliary Obstruction
07:44

Endoscopic Ultrasound-Guided Biliary Drainage: Endoscopic Ultrasound-Guided Hepaticogastrostomy in Malignant Biliary Obstruction

Published on: March 25, 2022

7.1K

Related Experiment Videos

Last Updated: Apr 16, 2026

Intraoperative Strategy under Complex Vascular Adhesion for Laparoscopic Radical Resection of Bismuth-Corlette Type IIIb Perihilar Cholangiocarcinoma
05:22

Intraoperative Strategy under Complex Vascular Adhesion for Laparoscopic Radical Resection of Bismuth-Corlette Type IIIb Perihilar Cholangiocarcinoma

Published on: February 13, 2026

197
Complete Laparoscopic Radical Resection of Perihilar Cholangiocarcinoma Type IIIb
04:50

Complete Laparoscopic Radical Resection of Perihilar Cholangiocarcinoma Type IIIb

Published on: January 17, 2025

953
Endoscopic Ultrasound-Guided Biliary Drainage: Endoscopic Ultrasound-Guided Hepaticogastrostomy in Malignant Biliary Obstruction
07:44

Endoscopic Ultrasound-Guided Biliary Drainage: Endoscopic Ultrasound-Guided Hepaticogastrostomy in Malignant Biliary Obstruction

Published on: March 25, 2022

7.1K

Area of Science:

  • Gastroenterology and Hepatology
  • Oncology

Background:

  • Primary sclerosing cholangitis (PSC) is a chronic, progressive liver disease associated with increased cancer risk.
  • Patients with PSC have a significantly elevated lifetime risk of developing cholangiocarcinoma (CCA), colorectal cancer (CRC), and potentially other malignancies.
  • The risk of certain cancers, like CRC, is further amplified in patients with concomitant inflammatory bowel disease (IBD).

Purpose of the Study:

  • To highlight the substantial cancer burden in patients with Primary Sclerosing Cholangitis.
  • To emphasize the increased risk of cholangiocarcinoma and colorectal cancer in PSC patients, especially those with IBD.
  • To propose a recommended screening protocol for various cancers in PSC patients.

Main Methods:

  • Review of existing literature and clinical data on cancer incidence in PSC patients.
  • Analysis of cancer risks in PSC patients with and without inflammatory bowel disease (IBD).
  • Formulation of screening recommendations based on identified risks.

Main Results:

  • Patients with PSC have a 10-15% lifetime risk of cholangiocarcinoma (CCA).
  • Concomitant PSC and IBD significantly increases colorectal cancer (CRC) risk (4-fold with IBD alone, 10-fold vs. general population).
  • Hepatocellular carcinoma (HCC) risk in PSC with cirrhosis is uncertain but potentially lower than in other cirrhotic causes.

Conclusions:

  • Routine screening for CCA, HCC, pancreatic, and gallbladder cancer using MRI/MRCP and CA 19-9 every 6 months is recommended for PSC patients.
  • Screening colonoscopy at diagnosis and surveillance colonoscopies every 1-2 years are advised for PSC patients with IBD.
  • Despite AASLD guidelines against routine liver tumor screening, proactive surveillance is crucial for early cancer detection in this high-risk population.